Aminopyridines and the treatment of spinal cord injury.

Abstract

Journal of NeurotraumaVol. 10, No. 1 Editorial: Aminopyridines and the Treatment of Spinal Cord InjurySTEPHEN G. WAXMANSTEPHEN G. WAXMANSearch for more papers by this authorPublished Online:26 Mar 2009https://doi.org/10.1089/neu.1993.10.19AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited ByPhase IIB Randomized Trial on the Use of 4-Aminopyridine in Guillain-Barré SyndromeArchives of Rehabilitation Research and Clinical Translation, Vol. 3, No. 2Surgical Neurostimulation for Spinal Cord Injury10 February 2017 | Brain Sciences, Vol. 7, No. 12Phase 2 trial of sustained-release fampridine in chronic spinal cord injury13 June 2006 | Spinal Cord, Vol. 45, No. 2Cellular transplantation strategies for spinal cord injury and translational neurobiologyNeuroRX, Vol. 1, No. 4Pharmacokinetics and safety of multiple oral doses of sustained-release 4-aminopyridine (fampridine-sr) in subjects with chronic, incomplete spinal cord injury 11A commercial party with a direct financial interest in the results of the research supporting this article has conferred or will confer a financial benefit on the author or 1 or more of the authors.Archives of Physical Medicine and Rehabilitation, Vol. 85, No. 1Low micromolar concentrations of 4-aminopyridine facilitate fictive locomotion expressed by the rat spinal cord in vitroNeuroscience, Vol. 126, No. 2Regulation and critical role of potassium homeostasis in apoptosisProgress in Neurobiology, Vol. 70, No. 4Pharmacokinetic Studies of Single and Multiple Oral Doses of Fampridine-SR (Sustained-Release 4-Aminopyridine) in Patients With Chronic Spinal Cord InjuryClinical Neuropharmacology, Vol. 26, No. 4Efficacy and Safety of 4-Aminopyridine in Patients with Long-Term Spinal Cord Injury: A Randomized, Double-Blind, Placebo-Controlled TrialPharmacotherapy, Vol. 23, No. 7Block of Na + ,K + -ATPase and Induction of Hybrid Death by 4-Aminopyridine in Cultured Cortical Neurons21 January 2003 | Journal of Pharmacology and Experimental Therapeutics, Vol. 305, No. 2Inactivation gating and 4-AP sensitivity in human brain Kv1.4 potassium channelBrain Research, Vol. 831, No. 1-24-Aminopyridine enhances motor evoked potentials following graded spinal cord compression injury in ratsBrain Research, Vol. 816, No. 2Randomized Double-Blind Crossover Trial of Fampridine-SR (Sustained Release 4-Aminopyridine) in Patients With Incomplete Spinal Cord Injury P. J. POTTER, K. C. HAYES, J. L. SEGAL, J. T. C. HSIEH, S. R. BRUNNEMANN, G.A. DELANEY, D. S. TIERNEY, and D. MASON29 January 2009 | Journal of Neurotrauma, Vol. 15, No. 10Effects of 4-Aminopyridine on Motor Evoked Potentials in Patients with Spinal Cord Injury J. QIAO, K.C. HAYES, J.T.C. HSIEH, P.J. POTTER, and G.A. DELANEY29 January 2009 | Journal of Neurotrauma, Vol. 14, No. 3Physiological and Theoretical Analysis of K + Currents Controlling Discharge in Neonatal Rat Mesencephalic Trigeminal NeuronsJournal of Neurophysiology, Vol. 77, No. 2Central conduction studies in patients with spinal cord injury and other forms of myelopathyJournal of Electromyography and Kinesiology, Vol. 5, No. 3Effect of 4-aminopyridine in acute spinal cord injurySurgical Neurology, Vol. 43, No. 5Treatment of Acute Injury of the Cervical SpineThe Journal of Bone & Joint Surgery, Vol. 76, No. 12 Volume 10Issue 1Jan 1993 To cite this article:STEPHEN G. WAXMAN.Editorial: Aminopyridines and the Treatment of Spinal Cord Injury.Journal of Neurotrauma.Jan 1993.19-24.http://doi.org/10.1089/neu.1993.10.19Published in Volume: 10 Issue 1: March 26, 2009PDF download